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ABSTRACT
An accumulation of antigen-presenting dendritic cells (DC) in the
thyroid gland, followed by thyroid autoimmune reactivity, occurs in
normal Wistar rats during iodine deficiency, and spontaneously in
diabetic-prone Biobreeding rats. This intrathyroidal DC accumula-
tion coincides with an enhanced growth rate and metabolism of the
thyrocytes, suggesting that both phenomena are related. Because DC
are known to regulate the hormone synthesis and growth in other
endocrine systems (i.e. the pituitary, the ovary, and the testis), we
tested the hypothesis that DC, known for their superb accessory cell
function in T cell stimulation, act as regulators of thyrocyte prolif-
eration (and hormone secretion).
We investigated the effect of (Nycodenz density gradient) purified
splenic DC from Wistar rats on the growth rate of and thyroid hor-
mone secretion by Wistar thyroid follicles (collagenase dispersion) in
culture. Various numbers of DC and follicles were cocultured during
24 h. The proliferative capacity of thyrocytes was measured by adding
tritiated thymidine (3H-TdR) and bromodeoxyuridine, the hormone
secretion into the culture fluid was measured by using a conventional
T3 RIA. Furthermore, antibodies directed against interleukin-1b (IL-
1b), IL-6, and tumor necrosis factor-a (TNF-a) were added to these
cocultures to determine the role of these cytokines in a possible DC
regulation of thyrocyte growth. Cocultures were also carried out in the
presence of antimajor histocompatibility complex-class I (MHC I),
anti-MHC II, antiintercellular adhesion molecule-1 (ICAM-1), and
antilymphocyte function-associated antigen-1a (LFA-1a) antibodies
to possibly interfere with DC-thyrocyte interactions.
The addition of DC to thyroid follicles clearly inhibited their 3H-
TdR uptake, particularly at a 10:1 ratio, in comparison to follicle
cultures alone, both under basal conditions and after TSH stimulation
(75 6 7% and 49 6 11% reduction, respectively, n 5 4). The follicle
T3 secretion (after TSH stimulation) was also suppressed by DC in
this system, but to a lesser extent (at best at an 1:1 ratio, 25 6 7%
reduction, n 5 4). The DC-induced inhibition of thyroid follicle growth
was totally abrogated after addition of anti-IL-1b antibodies; anti-
IL-6 only had effect on the DC inhibition of non-TSH-stimulated
thyrocytes, whereas anti-TNF-a demonstrated no effect at all. The
antibodies to MHC and to adhesion molecules had also no effect on
this DC-induced growth inhibition. The effect of the different anti-
cytokine and anti-adhesion antibodies on the T3 secretion from thy-
roid follicles was not investigated.
The clear inhibition of thyrocyte growth by splenic DC (classical
antigen-presenting cells) again demonstrates the regulatory role of
DC in endocrine systems. Proinflammatory cytokines such as IL-1b
and IL-6 are important mediators in this regulation. The here shown
dual role of DC represents a link between the immune and endocrine
system, which may form the gateway to the understanding of the
initiation of thyroid autoimmune reactions and the thyroid autoim-
mune phenomena seen in iodine deficiency. (Endocrinology 139:
3148–3156, 1998)
DESPITE RELATIVELY SIMPLE treatment, 1.6 billionpeople are still at risk for iodine deficiency. The effects
of iodine deficiency on individuals are (severely) impaired
mental and physical development, hypothyroidism, and en-
demic goitre development. Although the latter phenomenon
is well established, it is still unknown which pathobiological
mechanisms play a role in the trophic and metabolic stim-
ulation of iodine-deprived thyrocytes. A raised serum TSH
(1), a deficiency of thyroid-derived antitrophic iodinated lip-
ids (2, 3) and a specific trophic action of thyroid reactive
antibodies (4, 5) have all been proposed and disputed (6, 7)
as driving forces behind iodine-deficient goitrogenesis.
With regard to the involvement of the immune system in
iodine-deficient goitrogenesis, we (8–10) previously de-
scribed an accumulation of monocyte-derived cells such as
macrophages (MF) and dendritic cells (DC) in human en-
demic goitre and in the thyroid glands of rats and mice a few
weeks after starting an iodine-deficient diet. Because DC are
antigen-presenting cells (APC) par excellence and the only
stimulators of naive T lymphocytes, these early DC/MF
accumulations were proposed as inducers of the relatively
mild thyroid autoimmune reactions, which often later de-
velop in endemic goitre patients (11, 12) and iodine-deficient
rats (8). Indeed, the first local sign of an autoimmune thy-
roiditis process is, in all animal models of spontaneous dis-
ease studied so far, the accumulation and cluster formation
of DC and MF in the thyroid gland (10, 13, 14). This accu-
mulation occurs prior to thyroid autoantibody formation and
prior to the influx of large numbers of T and B cells. Relevant
to this report is that the diabetic-prone Biobreeding (BB-DP)
rat, one of the animal models of spontaneous thyroid auto-
immune disease, shows the formation of a small goitre at the
time of the early intrathyroid accumulation of DC (15). The
question thus arises whether there is a relationship between
goitre formation and DC accumulation.
There is a growing body of evidence that locally accumu-
lated DC and MF are not only acting as APC and effector
cells in host defence, but also as cells involved in morpho-
genesis (woundhealing and matrix repair; 16) and, more
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relevant to this report, in the regulation of growth and func-
tion of various endocrine cells (17), i.e. of anterior pituitary
cells, ovarian granulosa cells, theca cells, luteal cells, and
testicular Leydig cells. MF- and DC-derived cytokines, in-
terleukin-1 (IL-1), IL-6 and tumor necrosis factor (TNF), are
thought to play a role in such immuno-endocrine regulatory
interactions (17).
This notion has led to the aim of this study, i.e. the inves-
tigation of the regulatory effects of rat splenic DC (excellent
APC) on particularly the growth, but also the function (thy-
roid hormone secretion) of rat thyrocytes in a thyroid follicle
culture system. Splenic DC and thyroid follicles were iso-
lated and enriched from Wistar rats, and subsequently
cocultured and their interactions studied by time lapse
cinematography. The tritiated thymidine (3H-TdR) and bro-
modeoxyuridine (BrdU) incorporation as well as the T3 re-
lease of thyrocytes exposed to DC under basal conditions and
under TSH stimulation was measured. Furthermore, the ef-
fect of neutralizing antibodies to IL-1b, IL-6, TNF-a, and to
major histocompatibility complex-class I (MHC I), MHC II,
intercellular adhesion molecule-1 (ICAM-1) and lymphocyte
function-associated antigen-1a (LFA-1a) was studied in this
DC-thyroid follicle coculture system.
Materials and Methods
Animals
Wistar rats were purchased from Harlan (Zeist, The Netherlands) and
were kept under controlled light conditions (12-h light, 12-h dark cycle)
throughout this study. A standard pelleted diet (0.35 mg iodine/kg;
AM-II, Hope Farms BV, Woerden, The Netherlands) and tap water were
provided ad libitum.
Isolation and 24 h reconstitution culture of thyroid follicles
Rats (females and males, 8–22 weeks of age) were asphyxiated with
carbon dioxide. Thyroid follicles were isolated as previously described
(15). Thyroid glands were excised and carefully trimmed of fat and
connective tissue. Subsequently, thyroid lobes were washed (4 C) in
calcium- and magnesium-free HBSS (Gibco BRL Life Technologies,
Breda, The Netherlands). The HBSS was removed and replaced with
dispersion solution, containing the following substances: HBSS supple-
mented with 475 U/ml collagenase (type II; Sigma Chemical Co., Axel,
The Netherlands) and 0.1 mg/ml DNase (type I, grade II; Boehringer
Mannheim BV, Almere, The Netherlands). Thyroid lobes were minced
and incubated for 30 min (37 C, 5% CO2, water-saturated atmosphere).
The tissue was then further mechanically disrupted by gentle pipetting.
Thyroid fragments were left to sediment during 1 min at 1 3 g and
released follicles present in the supernatant were harvested and kept at
4 C. Fresh dispersion solution was added to the remaining undigested
tissue for 10 min and the above described procedure was repeated. After
several reincubation steps the dissociation of thyroid tissue was
complete.
The obtained suspension of thyroid follicles was washed twice with
ice-cold HBSS containing 0.1 mg/ml DNase and centrifuged for 2 min
at 50 3 g. The pellet consisted of intact and partly fragmented follicles.
Single follicular and endothelial cells, fibroblasts, and cell debris re-
maining in the supernatant were discarded. The isolated follicles were
resuspended and cultured in Ham’s F-12 medium (Gibco), supple-
mented with a 5-hormone and peptide mixture containing 10 mg/ml
insulin (Sigma), 10 nm hydrocortisone (Sigma), 5 mg/ml transferrin
(Sigma), 10 ng/ml glycyl-l-histidyl-l-lysine-acetate (Sigma), 10 ng/ml
somatostatin (Sigma) and 1% (vol/vol) heat-inactivated (30 min, 56 C)
FCS (Integro BV, Zaandam, The Netherlands). The following antibiotics
were also added: 100 U/ml penicillin (Seromed, Biochrom, Berlin, Ger-
many), 0.1 mg/ml streptomycin (Seromed), and 2.5 mg/ml amphotericin
(Boehringer).
At 24 h after initial isolation (37 C, 5% CO2, water-saturated atmo-
sphere), the partly fragmented follicles became spheric-like structures
again and contained 30–50 thyrocytes per follicle as judged by using an
inverted microscope and hematoxylin-eosin staining, respectively.
Determination of thyrocyte proliferation in reconstituted
thyroid follicles stimulated for 24 h
The reconstituted follicles were washed and seeded in 24-wells plates
(Costar Europe Ltd., Badhoevedorp, The Netherlands) at an averaged
density of 1000 follicles/well (proliferation in thyroid follicles, see be-
low) or 2000 follicles/well (thyroid hormone secretion by thyroid fol-
licles, see below). Bovine-TSH (Sigma; concentrations ranging from 1 z
1021 to 5 z 102 mU/ml) and 0.1 mm KI (Merck, Darmstadt, Germany) were
added to the follicles. At this stage, splenic DC were also added at
various ratios to the thyroid follicles (see below, Coculture of splenic
dendritic cells and thyroid follicles). The follicles were cultured for another
24 h. Basal controls consisted of cultures in the absence of TSH.
The proliferation assays were designed to examine the entry of cells
into the S-phase of the cell cycle. Two methods were used.
Tritiated thymidine uptake. Thyroid follicles were 3H-TdR labeled during
the last 5 h of the 24 h exposure to TSH.
In brief, the follicles were washed and put on fresh Ham’s F12 me-
dium (plus supplements and different concentrations TSH) in 96-wells
plates (Costar). Subsequently, 1 mCi/well methyl-3H-TdR (Amersham
International, Buckinghamshire, UK) was added. After the mentioned
labeling period at 37 C in a 5% CO2 water-saturated incubator, the
follicles were harvested on filter paper and radioactivity was counted in
a liquid scintillation analyzer (LKB Betaplate, Wallac, Turku, Finland).
In some experiments, follicles were (a) cocultured with 5 mg/ml
aphidicolin (inhibitor DNA polymerase, 18; Sigma) during or (b) 2,000
rad X-irradiated before TSH exposure. These treatments were applied to
prevent replication of DNA, and thus to ascertain that measured ra-
dioactivity in the samples without these treatments reflect the S-phase
of the cell cycle. In other words; exclusion of erroneous positive mea-
surements, as discussed by Maurer (19). Each individual experiment was
done in duplicate.
5-Bromo-29-deoxyuridine labeling. The follicles were incubated at 37 C in
a 5% CO2 water-saturated incubator in the presence of 10 mm BrdU
(BrdU-kit I; Boehringer) during the last 5 h before the 24 h of TSH
stimulation ended. Thereafter, the samples were thoroughly washed in
0.01 m PBS (Merck), cytocentrifuged onto glass slides, air-dried, and
fixed in precooled 70% (vol/vol) ethanol (Merck) during exactly 30 min
at 220 C.
The BrdU incorporation was immunocytochemically visualized ac-
cording to the instructions of the manufacturer (see above) with slight
modifications: 1) incubation with anti-BrdU antibody, diluted 1:10 in the
manufacturer’s incubation buffer (containing nucleases that allow access
to BrdU without denaturation of DNA), during 40 min at 37 C; 2)
washing steps (33) in PBS; 3) incubation with antimouse-immunoglobu-
lins antibody, conjugated with fluorescein isothio-cyanate, diluted 1:10
in PBS containing 0.1% (wt/vol) BSA (Sigma), during 45 min at 37 C; 4)
washing steps (33) in PBS. The cytospin preparations were mounted in
a solution containing 90% (vol/vol) glycerol (Sigma) and 2.3% (wt/vol)
1,4-diazobicyclo-(2,2,2)-octane (Sigma) to delay fading of the fluorescent
dye during examination using an ordinary fluorescence microscope
(Zeiss, Weesp, The Netherlands). The percentage BrdU-positive (BrdU1)
follicles was evaluated by counting at least 500 follicles/sample. For
negative controls, the primary antibody incubation step consisted of
buffer solution without anti-BrdU antibody.
This thyroid follicle system also enabled us to determine the thyroid
hormone secretion into the culture fluid. After 24 h of exposure to TSH,
the culture supernatants were centrifuged (500 3 g, 5 min), carefully
aspirated (devoid of thyrocytes) and stored at 220 C until T3 levels were
determined. The T3 contents in these supernatants were measured by a
conventional RIA (Dr. T. J. Visser, Dr. R. Docter, Mr. H. van Toor,
Department of Internal Medicine, University Hospital Dijkzigt, Rotter-
dam, The Netherlands). T3 standards were diluted in Ham’s F12 me-
dium plus supplements. Each individual supernatant sample was as-
sayed in duplicate.
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Isolation of splenic dendritic cells and mixed leucocyte
reaction
Splenic DC from Wistar rats were enriched according to the method
of Knight et al. (20), with slight modifications. Briefly, the spleen was
minced and digested for 1 h at 37 C in RPMI 1640 (Gibco) containing:
125 U/ml collagenase (type III; Gibco) and 0.1 mg/ml DNase. The
remaining tissue was teased through a (105 mm) filter and the erythro-
cytes were removed by lysis. Finally, the cells were washed and cultured
in RPMI 1640 supplemented with 10% FCS and antibiotics. After an
overnight culture period in culture flasks (Costar; 37 C, 5% CO2 incu-
bator), the DC were isolated from the nonadherent cells by using a 14.5%
(wt/vol) Nycodenz (Nycomed Pharma As, Oslo, Norway) density gra-
dient (800 3 g for 20 min). Low density cells were collected from the
interphase, thoroughly washed in PBS/0.5% BSA and put on RPMI 1640
with 10% FCS and antibiotics. This cell fraction demonstrated in 70–95%
of cells a dendritic morphology, a strong MHC II expression, and ab-
sence of acid phosphatase activity.
For the mixed leucocyte reaction (MLR), splenic T lymphocytes were
isolated from the (high density cells) pellet fraction after 14.5% Nyco-
denz density gradient centrifugation. T lymphocytes were separated
from B lymphocytes and some residual MF by using a nylon wool
column (Polyscience Ltd., Eppelheim, Germany) during 1 h in 5% CO2
incubator. These responder T (80–90% CD31) cells were used in the MLR
by adding stimulator (2,000 rad irradiated) DC at various ratios (fixed
number of 150,000 T cells/well) in a 96-wells plate, and were subse-
quently cultured for 5 days in RPMI 1640 containing 50 mm HEPES
buffer (Gibco), 110 mg/ml Na-pyruvate (Merck), 0.5‰ (vol/vol) b-mer-
capto-ethanol (Merck) and antibiotics. T cell proliferation was measured
via 3H-TdR incorporation (0.5 mCi/well during the last 16 h of total
culture period).
To study the role of MHC and adhesion molecules in this MLR,
neutralizing antibodies against MHC I (rat RT1A; 1:1000; Serotec Ltd.,
Oxford, UK) and MHC II (rat RT1B; 1:400; Serotec), and against LFA-1a
(rat CD11a; 1:50; Serotec) and ICAM-1 (rat CD54; 1:50; Serotec) were
added on the first and second day of a total culture period of 3 days. Each
individual experiment was done in triplicate.
Coculture of splenic dendritic cells and thyroid follicles
Splenic DC (in hormone supplemented Ham’s F-12 medium) were
2,000 rad X-irradiated to prevent proliferation and cocultured with thy-
roid follicles at various ratios (10:1, 1:1 and 1:10) for 24 h (with and
without addition of TSH 100 mU/ml). Before coculturing, the thyroid
follicle suspensions (24 h after initial isolation) were checked for possible
presence of residual DC. A cytochemical staining method (against MHC
II) was used for this purpose and demonstrated that these suspension
contained no DC.
After the period of coculture, the effect of splenic DC on thyroid
follicle 3H-TdR (and BrdU) uptake and T3 release was measured (see
above, Determination of thyrocyte proliferation in reconstituted thyroid fol-
licles stimulated for 24 h). The viability of the thyroid follicles and DC
remained unchanged when cultured alone or cocultured (data not
shown). Control cultures consisted of thyroid follicles and splenic DC
alone (with and without TSH 100 mU/ml).
In some experiments (n 5 3), the specificity of the DC effect on
thyrocyte proliferation and T3 release was tested by fixing DC in a 4%
(vol/vol) formaldehyde-PBS solution (Merck) for 20 min at room tem-
perature before adding these DC to the follicles. This procedure pre-
vented the motility of (as verified by time lapse video recording, see
below) and production of cytokine(s) by DC.
To establish whether cytokines (IL-1b, IL-6 and TNF-a) or adhesive
interactions (MHC I and II, and LFA-1a/ICAM-1) might contribute to
the effect of DC on the examined thyrocyte growth, the following an-
tibodies were added to our coculture system (DC:follicle ratio of 1:1) for
24 h: antihuman II-1b (1:5000; Glaxo, Geneva, Switzerland), antirat IL-6
(1:100; kindly provided by Dr. J. Gauldie, Department of Pathology,
McMaster University, Hamilton, Canada), antihuman TNF-a (1:1000; a
kind gift from Dr. W. A. Buurman, Department of Surgery, University
of Limburg, Maastricht, The Netherlands), antirat MHC I and II (see
above, Isolation of splenic dendritic cells and mixed leucocyte reaction), antirat
LFA-1a and ICAM-1 (see above). Each individual experiment was done
in duplicate.
Time lapse cinematography
To investigate DC motility and cell-cell interactions between DC and
thyroid follicles under the various above described coculture conditions,
time lapse cinematographic studies were performed. Again, DC and
thyroid follicles (ratio 1:10), with or without the various anticytokines
or antiadhesions, were cocultured and recorded during 45 min in a
microincubator (37 C, 5% CO2) on an inverted microscope (Axiovert,
Zeiss) attached to a video camera (Sony Co., Japan) and a time lapse
video recorder (Panasonic, Matsushita Electric Industrial Co., Osaka,
Japan). The video recording interval was set at 0.18 sec and the tape
running speed at 2.599 mm/sec. After recording, the images were an-
alyzed using a computer (Acorn Computers Ltd., Cambridge, UK).
FIG. 1. The 3H-TdR incorporation in (A, n 5 4–16), the percentage of
positive BrdU labeled (B, n 5 7–15) and the T3 secretion by (C, n 5
7–14) Wistar thyroid follicles kept in suspension culture under basal
conditions and stimulated by various concentrations TSH. *, P , 0.05;
**, P , 0.01; ***, P , 0.001 stimulated vs. basal conditions.
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Statistical analysis
The results are presented as means 6 sem and statistical analysis was
performed using the two-tailed and paired Students’ t test.
Results
Effects of the coculture of splenic dendritic cells with
thyroid follicles on thyrocyte proliferation and T3 secretion
In a first set of experiments, we established the time- and
dose-dependent effects of the spontaneous and TSH-induced
3H-TdR uptake in and T3 release from Wistar thyroid follicles
in suspension culture. During the follicle reconstitution time
(first 24 h after isolation), there was hardly any 3H-TdR
uptake (,100 cpm). Maximal 3H-TdR uptake was obtained
in follicle cultures of 24 h after the reconstitution time. Dur-
ing this time, detectable amounts of T3 were also released in
the culture fluid. Exposure to TSH during these 24 h in-
creased both the 3H-TdR uptake and the T3 release in a
dose-dependent manner (Fig. 1, A and C), 100 mU/ml being
the most optimal dosage for measuring both T3 release and
3H-TdR incorporation in our assay system. The specificity of
the 3H-TdR uptake with regard to true DNA proliferation
was demonstrated with aphidicolin and X-irradiation treat-
ment. Both treatments reduced .80% (n 5 5) of the total
measured incorporated radioactivity (spontaneous and TSH-
stimulated). This reduction could not be ascribed to cyto-
toxicity of aphidicolin or X-irradiation: none of the follicles
showed a change in viability (trypan blue exclusion test) or
an altered morphology, and moreover the T3 release re-
mained unchanged (data not shown). In accordance with the
3H-TdR uptake, our assay system showed a clearly measur-
able BrdU labeling of the thyroid follicles with TSH at 100
and 500 mU/ml after 24 h of culture (Fig. 1B). Under basal
(non-TSH-stimulated conditions) , 5 BrdU1 nuclei per fol-
licle were always found, whereas exposure to TSH often
resulted in 10–20 BrdU1 nuclei per follicle.
Addition of 6 propyl-2-thiouracil (Sigma; 2 mm), during
the 24-h culture period after follicle reconstitution, clearly
inhibited basal and TSH-stimulated T3 levels in the culture
fluid (data not shown) indicating that the hormone measured
in the culture supernatants was mainly due to secretion
rather than from aspecific release.
On the basis of the above-described findings, we decided
to use a culture period of 24 h and a dosage of 100 mU/ml
TSH for stimulation, and to consider the 3H-TdR incorpo-
ration as a reliable parameter of thyrocyte proliferation.
In a second set of experiments, we verified the accessory
capability of the splenic DC population. As expected, the
Wistar rat splenic DC (Nycodenz-enriched low density
splenic cell fraction) were potent stimulators of syngeneic T
lymphocytes in MLR (Fig. 2). Already at a ratio of 1:40 (DC:T
FIG. 2. The 3H-TdR incorporation into
Wistar T lymphocytes stimulated by
syngeneic splenic DC in a mixed leuco-
cyte reaction (n 5 7–8). In the added
table the blocking effect (n 5 3) of the
listed antibody is given at the indicated
DC:T cell ratio. Effective antibody dilu-
tions interfering with DC clustering
were 1:50 for anti-LFA-1a and anti-
ICAM-1, 1:1000 for anti-MHC I and
1:400 for anti-MHC II; these effective
dilutions have been used in this set of
experiments and Fig. 5. (ND, Not de-
termined).
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cell) high incorporation values of around 70,000 cpm were
found. In contrast, resident peritoneal MF or unfractionated
splenic cells were hardly capable of stimulating syngeneic T
cells (values of at best 2,000–3,000 cpm were reached at a
ratio 1:1), illustrating the superb stimulatory capability of
splenic DC.
The addition of the splenic dendritic APC to syngeneic
thyroid follicles resulted in a much lower 3H-TdR and BrdU
uptake by the thyrocytes both under basal and TSH-stimu-
lated conditions (Fig. 3). In the case of 3H-TdR uptake values
between 25–75% DC-induced inhibition were found depend-
ing on the ratio DC:follicle and the conditions; the strongest
inhibition was found under basal conditions and at a ratio of
1:10 (follicle:DC), viz. 25 6 7% of control (5 thyroid follicle
culture in the absence of DCs, Fig. 3). The decreased BrdU
labeling largely confirmed the 3H-TdR uptake data, however,
values only (probably because of the semiquantitative nature
of this method) reached statistical significance under non-
TSH-stimulated conditions and at a ratio of 1:10 (follicle:DC,
71 6 6% of control, Fig. 3). With regard to the T3 secretion,
splenic DC induced a subtle but consistent inhibition (i.e.
75 6 7% of control) on TSH-stimulated thyroid follicles at a
ratio of 1:1 (Fig. 3). The T3 release in cocultures not stimulated
with TSH was not affected by the presence of splenic DC.
Time lapse phase-contrast cinematographic studies of the
DC-thyroid follicle cocultures showed that DC were very
active in the system (Fig. 4). They had more or less rounded
or elongated shapes and the vast majority were constantly
extending and withdrawing long cytoplasmic veils ap-
proaching and touching the thyroid follicles. The dendritic
(or veiled) cells often formed small cell clusters with each
other (containing 4–8 cells, so-called homotypic clustering),
and some of these DC clusters also made contact with the
thyroid follicles. The contacts of DC with the thyroid follicles
varied from short (mere touching at several spots of the
thyroid follicle) to longlasting and firm. During these firm
contacts, the actively moving DC were able to tilt a whole
thyroid follicle. When formaldehyde-fixed DC were used in
this coculture system, their moving and active behavior were
completely lost as well as their homotypic clustering and
contacting with the thyroid follicles. This treatment also re-
sulted in a complete abrogation (data not shown; n 5 3) of
the inhibitory effects of splenic DC on both the 3H-TdR up-
take (basal and TSH stimulated) and the T3 release (TSH
stimulated).
Effects of neutralizing antiadhesion antibodies on DC-
thyroid follicle interactions
Because the intensive physical interactions of the splenic
DC with the thyroid follicles suggest the involvement of
adhesion molecules and because the DC constitutively ex-
pressed MHC I, MHC II, LFA-1a, and ICAM-1, whereas
thyroid follicles were positive for ICAM-1 and LFA-1a (data
not shown), we added anti-MHC I, anti-MHC II, anti-LFA-
1a, and anti-ICAM-1 antibodies to the coculture system.
Before these experiments, the effect of these antibodies and
their effective dilutions were studied on homotypic cluster-
ing of splenic DC and APC capability in syngeneic MLR.
Effective dilutions for interfering with DC clustering ap-
FIG. 3. The effect of Wistar splenic DC on the growth of and T3 secretion (black bars, n 5 4) by Wistar thyroid follicles kept in suspension culture
under basal (left panel) and TSH-stimulated (right panel) conditions. Follicle growth was measured by 3H-TdR incorporation (open bars, n 5
4–17) and by BrdU labeling (shaded bars, n 5 4–5). Basal or TSH-stimulated (100 mU/ml) outcomes in the absence of DC were set at 100%
(dotted line) in each separate experiment because these outcomes showed considerable interassay variation in this set of experiments (3H-TdR
incorporation: basal 1673 6 227 cpm/1000 follicles, range 247–3777 cpm and TSH-stimulated 4438 6 483 cpm/1000 follicles, range 1070–8888
cpm; BrdU labeling: basal 18 6 4% BrdU1 follicles, range 12–28% and TSH-stimulated 52 6 1% BrdU1 follicles, range 50–55%; T3 secretion:
basal 194 6 14 fmol/2000 follicles, range 155–220 fmol and TSH-stimulated 309 6 37 fmol/2000 follicles, range 250–320 fmol). Despite this
variation, coculture with DC invariably gave a clear inhibition of 3H-TdR incorporation or BrdU labeling, and of T3 secretion. *, P , 0.05; **,
P , 0.01; ***, P , 0.001 presence vs. absence of DC in thyroid follicle cultures. (ND, Not determined).
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peared to be 1:50 for anti-LFA-1a and anti-ICAM-1, 1:1000 for
anti-MHC I, and 1:400 for anti-MHC II. The homotypic clus-
tering was delayed for several hours (2–3 h) by the addition
of anti-LFA-1a and anti-ICAM-1; normally homotypic clus-
tering starts at 30 min to 1 h. The anti-MHC I and anti-MHC
II intensified the homotypic clustering of DC and very large
clusters of over 50 cells (1.5 3 105 DC/well) were detected
after 30 min in culture. With regard to the accessory capa-
bility of the splenic DC, the antiadhesion and the anti-MHC
antibodies clearly reduced this function of these cells in syn-
geneic T cell MLR (Fig. 2).
Despite their clear effects on the immune functions of the
splenic DC, the antibodies were not able, using the above
indicated dilutions, to interfere with the DC-induced inhib-
itory effects on 3H-TdR uptake of thyroid follicles (Fig. 5, both
basal and TSH-stimulated conditions). In the absence of the
splenic DC these antibodies had also no effect on the 3H-TdR
uptake of thyrocytes (Fig. 5). By using time lapse cinema-
tography it appeared that the antibodies were effective in our
follicle-DC coculture system because homotypic DC cluster-
ing was affected in the system; the interactions of splenic DC
with thyroid follicles were, however, similar in the presence
or absence of anti-MHC I, anti-MHC II, anti-LFA-1a, and
anti-ICAM-1.
Effects of neutralizing anticytokine antibodies on DC-
induced inhibition of thyrocyte 3H-TdR uptake
To determine whether IL-1b, IL-6, and TNF-a were in-
volved in the antiproliferative effect of splenic DC on thyroid
follicles, experiments with neutralizing anticytokine anti-
bodies were performed. In earlier published experiments, we
had established the effective dilutions of these antibodies to
neutralize the bioactivity of their target cytokines in the ap-
propriate bioassays (21, 22).
Anti-IL-1b antibodies (1:5000) were able to abrogate the
DC-induced inhibition of 3H-TdR uptake in thyroid follicles,
both under basal and TSH-stimulated conditions (Fig. 6).
This shows a key role of IL-1b in the thyrocyte antiprolif-
erative effect of splenic DC. The 3H-TdR uptake of thyroid
follicles in the absence of DC was not affected by the anti-
IL-1b antibodies, demonstrating that the cytokine was not
involved in thyrocyte proliferation under these conditions of
the assay system.
Anti-IL-6 antibodies (1:100) showed a strong stimulating
effect on thyrocyte proliferation in the absence of splenic DC
(P , 0.01) but only under basal (non-TSH-stimulated) con-
ditions (Fig. 6). This suggests an antiproliferative effect of
thyrocyte-derived IL-6 under basal conditions (note: DC are
absent from these reconstituted follicles). The anti-IL-6 an-
tibodies were also able to completely abrogate the DC-in-
duced inhibition of thyrocyte 3H-TdR uptake under non-
TSH-stimulated conditions (Fig. 6), hence an involvement of
this cytokine in DC-thyrocyte interactions is most likely.
Anti-TNF-a antibodies (1:1000) had a dampening effect
(P , 0.05) on TSH-stimulated 3H-TdR uptake of thyroid
follicles (Fig. 6), indicating that this cytokine (thyrocyte-de-
rived?) stimulates thyrocyte proliferation. No neutralizing
effect of anti-TNF-a could be found on the thyrocyte growth
inhibiting effect of added splenic DC (Fig. 6).
Discussion
This study shows that rat splenic DC, apart from being
excellent APC in MLR, also regulate the proliferation (and to
some extent the thyroid hormone release) of thyrocytes in a
rat thyroid follicle in vitro coculture system. Also in vivo,
albeit in other endocrine systems, similar endocrine down-
regulating effects of monocyte-derived cells have been de-
scribed: Gu et al. (23) detected, after preventing the influx of
DC/MF in the pancreas, a slight but consistent (25%) in-
crease of islet and duct cell growth in interferon-g transgenic
mice, and Gaytan et al. (24) observed raised testosterone
levels in rats after DC/MF depletion of the testis. Whether
an in vivo blockade of the intrathyroid accumulation of DC
(e.g. via the usage of the antibodies ED 7 and ED 8; Ref. 25)
leads to an even more enhanced proliferation of thyrocytes
in iodine-deficient Wistar rat goitre or in BB-DP rat goitre
needs to be investigated.
FIG. 4. Photographs of time lapse phase-contrast cinematography
demonstrating the interactions of two active veiled splenic DC (1, 3)
with each other, with nonactive rounded DC (2) and with two thyroid
follicles (TF) in suspension culture. Four sequential pictures (A–D)
are given 2 min apart. Note the moving and active behavior of the
veiled DC and the short contacts established with each other and the
thyroid follicles. Magnification, 31000; bar, 10 mm.
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Our study also shows that the cytokine IL-1b is a key
controlling signal in the in vitro DC-down-regulated thyro-
cyte growth. IL-6 also contributed to the immuno-endocrine
interaction, but only under non-TSH-stimulated conditions.
TNF-a, if any, had a growth promoting effect in our culture
system. Though epidermal DC (the Langerhans cells) have
been described as major sources of IL-1b and IL-6 (26), it is
the general concept that cells belonging to the DC series are
poor producers of these cytokines. In our experience (lung
DC; 27) and that of others (28, 29), DC do not or hardly
produce IL-1b and IL-6. Nevertheless, DC-derived IL-1b sig-
nals play a major role in DC-induced T cell proliferation as
shown in cytokine neutralization experiments (27) and ap-
parently also in DC-thyrocyte regulation (see this report).
Effects of IL-1b and IL-6 on thyrocyte growth and function
have amply been described. In the majority of the reported
FIG. 5. The effects of anti-MHC I, anti-MHC II, anti-LFA-1a, and anti-ICAM-1 antibodies (ab) on the 3H-TdR incorporation of thyroid follicles
in suspension culture under basal (left panel) and TSH-stimulated (right panel) conditions (n 5 3–5). Coculture conditions (presence/absence
of DC and/or ab) are given at the top of the figure. See Fig. 3 for explanation of dotted line (basal 1977 6 470 cpm/1000 follicles, range 1268–3777
cpm; TSH-stimulated 4599 6 1176 cpm/1000 follicles, range 2061–8888 cpm) and P values.
FIG. 6. The effects of anti-IL-1b
(1:5000), anti-IL-6 (1:100), and anti-
TNF-a (1:1000) antibodies on the 3H-
TdR incorporation of thyroid follicles in
suspension culture under basal condi-
tions (left panel) and TSH-stimulated
(right panel) conditions (n 5 7–9). See
Fig. 3 for explanation of dotted line
(basal 1183 6 219 cpm/1000 follicles,
range 247–2556 cpm; TSH-stimulated
3666 6 595 cpm/1000 follicles, range
1070 –7328 cpm) and P values.
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experiments the cytokines inhibit differentiated functions
such as thyroid peroxidase expression, thyroglobulin release,
iodide uptake, and T3 secretion; reports on stimulation, how-
ever, also exist (reviewed in Refs. 30 and 31). The effect of
these cytokines on thyrocyte proliferation is also conjectural.
Upon injection, IL-1a and IL-1b stimulate thyroid growth in
rats (32), and IL-1a promotes the growth of a thyroid car-
cinoma cell line via Ca21/calmodulin pathways (33). In con-
trast, the group of Ga¨rtner found no effect of IL-1b on thy-
rocyte proliferation using a porcine thyroid follicle culture
system (34). IL-6 was described as not affecting basal cell
proliferation of FRTL-5 cells, it stimulated DNA-synthesis in
a dose-dependent manner in the presence of TSH (35). This
growth promoting effect of IL-6 is, however, controversial
and Zeki et al. (36) have reported very little effect on FRTL-5
cell proliferation. Our data give evidence for a growth in-
hibiting effect of DC-derived IL-1b and IL-6. Obviously, cul-
ture conditions (the state of the thyrocytes and the DC), local
cytokine concentrations (31), and possibly other cofactors
provided in the close DC-thyrocyte interactions may play a
role as well. With regard to the growth-inhibiting effect of
DC-derived IL-1b, it is also worthy to note that recent reports
show that this cytokine induces Fas expression on thyrocytes,
subsequently leading to the apoptosis of the thyrocytes (37).
Whether DC are able to induce Fas expression on rat thy-
rocytes in our culture system needs further investigation.
Our cinematographic study showed that the DC were very
active, moving around and touching the thyroid follicles,
while constantly extending and withdrawing their veils. In
some cases the DC made firm contacts with the follicles and
were able to tilt the follicles. It is possible that these close
contacts allow an efficient and special local cytokine signal-
ling between the DC and the thyrocytes, explaining the
above-discussed IL-1b (and IL-6) induced inhibiting action
on thyrocyte proliferation. A specific triggering of the ad-
hesion molecules (receptors in itself) may also play a role in
the DC-induced thyrocyte growth inhibitory action; indeed,
DC constitutively express many adhesion molecules (38),
whereas thyrocytes acquire such molecules on their surface
after cytokine/TSH stimulation (39). However, antibodies to
MHC I and II and to ICAM-1 and LFA-1a had no effect on
the contacting behavior and the growth controlling action of
DC on thyrocytes in coculture. These antibodies did show an
effect on the physical and functional interactions between DC
and T lymphocytes. This argues against at least a role of
MHC molecules and LFA-1a/ICAM-1 in the functional con-
tacts between DC and thyrocytes. It is obvious that other
adhesion molecules need to be tested in future experiments.
What could be the molecular signals attracting the DC to
the thyroid? In the nonobese diabetic mouse, DC infiltration
can be triggered by inducing thyrocyte necrosis via iodine-
intoxication (10). In the thyroid of the BB-DP rat, the infil-
tration of DC occurs spontaneously at around 10 weeks of
age, in the absence of early microscopic thyrocyte necrosis
(13, 40, 41). At that time, isolated BB-DP thyrocytes produce
in vitro more T4 and IL-6 as compared to age-matched Wistar
thyrocytes (15), and these molecules may be instrumental in
the local accumulation of DC because thyroid hormones and
IL-6 are in vitro active in the monocyte to DC transition (42).
Monocyte chemoattractant protein-1 (MCP-1) and granulo-
cyte-macrophage colony-stimulating factor (GM-CSF) are
known regulators for the attraction (43) and maturation (42)
of monocyte-derived DC. However, MCP-1 is not expressed
in the thyroid of 10-week-old BB-DP rats but becomes ex-
pressed later when lymphocytic infiltrates are present (15).
IL-1 has been described as inducing MCP-1 and GM-CSF
expression in cultured thyrocytes (44, 45). Hence, a scenario
can be envisioned where DC accumulated in the thyroid by
yet unknown signals (IL-6?) provide IL-1 stimuli to the
neighboring thyrocytes, upon which these endocrine cells are
not only regulated in their proliferation but also start to
secrete cytokines (MCP-1, GM-CSF) that further stimulate
the accumulation of DC.
In conclusion, the present study shows that classical APC,
such as the DC, inhibit the in vitro growth (and hormonal
output) of thyrocytes and that IL-1b and to a lesser extent
IL-6 are involved. Further studies are needed to establish the
in vivo effects of DC on thyroid growth itself and a possible
involvement of Fas molecules. Unveiling the effect of intra-
thyroidal DC on the growth of neighboring thyrocytes will
probably lead to a better understanding of the initial inter-
actions between thyrocytes and immune cells during the
development of iodine-deficient goitre and thyroid autoim-
mune disease.
Acknowledgments
We are indebted to Mr. Tar van Os for preparation of the figures, Mr.
Ed Landsbergen and Mr. John Mahabier for animal care, and Mrs. Petra
Assems for typographical support.
References
1. Stu¨bner D, Ga¨rtner R, Greil W, Gropper K, Brabant G, Permanetter W, Horn
K, Pickardt CR 1987 Hypertrophy and hyperplasia during goiter growth and
involution in rats—separate bioeffects of TSH and iodine. Acta Endocrinol
116:537–548
2. Dugrillon A, Ga¨rtner R 1995 d-Iodolactones decrease epidermal growth fac-
tor-induced proliferation and inositol-1,4,5-trishosphate generation in porcine
thyroid follicles—a possible mechanism of growth inhibition by iodide. Eur J
Endocrinol 132:735–743
3. Pisarev MA, Krawiec L, Juvenal GJ, Bocanera LV, Pregliasco LB, Sartorio G,
Chester HA 1994 Studies on the goiter inhibiting action of iodolactones. Eur
J Pharmacol 258:33–37
4. Wilders-Truschnig MM, Drexhage HA, Leb G, Eber O, Brezinschek HP,
Dohr G, Lanzer G, Kreys GJ 1990 Chromatographically purified immuno-
globulin G of endemic and sporadic goiter patients stimulates FRTL-5 cell
growth in a mitotic arrest assay. J Clin Endocrinol Metab 70:444–452
5. Medeiros-Neto GA, Halpern A, Cozzi ZS, Lima N, Kohn LD 1986 Thyroid
growth immunoglobulins in large multinodular endemic goitres: effect of
iodized oil. J Clin Endocrinol Metab 63:644–650
6. Weetman AP 1994 Is endemic goiter an autoimmune disease? J Clin Endocrinol
Metab 78:1017–1019
7. Drexhage HA 1996 Autoimmunity and thyroid growth. Where do we stand?
Eur J Endocrinol 135:39–45
8. Mooij P, Wit de HJ, Bloot AM, Wilders-Truschnig MM, Drexhage HA 1993
Iodine deficiency induces thyroid autoimmune reactivity in Wistar rats. En-
docrinology 133:1197–1204
9. Wilders-Truschnig MM, Kabel PJ, Drexhage HA, Beham A, Leb G, Eber O,
Heberstreit J, Loidolt D, Dohr G, Lanzer G, Kreys GJ 1989 Intrathyroidal
dendritic cells, epitheloid cells and giant cells in iodine deficient goiter. Am J
Pathol 135:219–225
10. Many M-C, Maniratunga S, Varis I, Dardenne M, Drexhage HA, Denef J-F
1995 Two step development of a Hashimoto-like thyroiditis in genetically
autoimmune prone non obese diabetic (NOD) mice. Effects of iodine-induced
cell necrosis. J Endocrinol 147:311–320
11. Fenzi GF, Giani C, Ceccarelli P, Bartalena L, Macchia E, Aghini-Lombardi
F, Vitti P, Lari R, Ceccarelli C, Baschieri L, Pinchera A 1986 Role of auto-
immune and familial factors in goiter prevalence. Studies performed in a
moderately endemic area. J Endocrinol Invest 9:161–164
12. Bretzel RG, Platzer A, Schaeffer R 1990 Immunopathological findings and
thyroid autoantibodies in thyroid autonomy. Acta Med Austriaca 17:20–24
DENDRITIC CELLS SUPPRESS THYROCYTE GROWTH 3155
 at Medical Library Erasmus MC on December 11, 2006 endo.endojournals.orgDownloaded from 
13. Voorbij HAM, Kabel PJ, Haan de M, Jeucken PHM, Gaag van der RD, Baets
de MH, Drexhage HA 1990 Dendritic cells and class II MHC expression on
thyrocytes during the autoimmune thyroid disease of the BB rat. Clin Immunol
Immunopathol 55:9–22
14. Hala K, Malin G, Dietrich H, Loesch U, Boeck G, Wolf H, Kaspers B, Geryk
J, Falk M, Boyd RL 1996 Analysis of the initiation period of spontaneous
autoimmune thyroiditis (SAT) in obese strain (OS) of chickens. J Autoimmun
9:129–138
15. Simons PJ, Delemarre FGA, Jeucken PHM, Drexhage HA, Pre-autoimmune
thyroid abnormalities in the biobreeding diabetes-prone (BB-DP) rat. A pos-
sible relation with the intrathyroid accumulation of dendritic cells and the
initiation of the thyroid autoimmune response. J Endocrinol, in press
16. Sueki H, Whitaker D, Buchsbaum M, Murphy GF 1993 Novel interactions
between dermal dendrocytes and mast cells in human skin. Implications for
hemostasis and matrix repair. Lab Invest 69:160–172
17. Hoek A, Allaerts W, Leenen PJM, Schoemaker J, Drexhage HA 1997 Dendritic
cells and macrophages in the pituitary and the gonads. Evidence for their role
in the fine regulation of the reproductive endocrine response. Eur J Endocrinol
136:8–24
18. Okugawa T, Itoh M, Murata Y, Seo H 1995 Effect of aphidicolin on DNA
synthesis in cultured human thyroid cells. Exp Clin Endocrinol 103:88–93
19. Maurer HR 1981 Potential pitfalls of [3H]thymidine techniques to measure cell
proliferation. Cell Tissue Kinet 14:111–120
20. Knight SC, Farrant J, Bryant A, Edwards AJ, Burman S, Lever A, Clarke J,
Webster AD 1986 Non-adherent, low-density cells from human peripheral
blood contain dendritic cells and monocytes, both with veiled morphology.
Immunology 57:595–603
21. Allaerts W, Jeucken PHM, Debets R, Hoefakker S, Claassen E, Drexhage HA
1997 Heterogeneity of pituitary folliculo-stellate cells: Implications for inter-
leukin-6 production and accessory function in vitro. J Neuroimmunol 9:43–53
22. Debets R, Hegmans JPJJ, Troost RJJ, Benner R, Prens EP 1995 Enhanced
production of biologically active IL-1a and IL-1b by psoriatic epidermal cells
ex vivo. Eur J Immunol 25:1624–1630
23. Gu D, O’Reilly L, Molony L, Cooke A, Sarvetnick N 1995 The role of infil-
trating macrophages in islet destruction and regrowth in a transgenic model.
J Autoimmun 8:483–492
24. Gaytan F, Bellido C, Aguilar E, Rooijen van N 1995 Pituitary-testicular axis
in rats lacking testicular macrophages. Eur J Endocrinol 132:218–222
25. Huitinga I, Damoiseaux JGMC, Do¨pp EA, Dijkstra CD 1993 Treatment with
anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic enceph-
alomyelitis in Lewis rat. Eur J Immunol 23:709–715
26. Heufler C, Topar G, Koch F, Trockenbacher B, Ka¨mpgen E, Romani N,
Schuler G 1992 Cytokine gene expression in murine epidermal cell suspen-
sions: interleukin 1b and macrophage inflammatory protein 1a are selectively
expressed in Langerhans cells but are differentially regulated in culture. J Exp
Med 176:1221–1226
27. Haarst van JMW, Verhoeven GT, Wit de HJ, Hoogsteden HC, Debets R,
Drexhage HA 1996 CD1a1 and CD1a2 accessory cells from human bron-
choalveolar lavage differ in allostimulatory potential and cytokine production.
Am J Respir Cell Mol Biol 15:752–759
28. Nicod LP, Galve-Rochemonteix de B, Dayer J-M 1990 Dissociation between
allogenic T cell stimulation and interleukin-1 or tumor necrosis factor pro-
duction by human dendritic cells. Am J Respir Cell Mol Biol 2:512–522
29. McKenzie JL, Prickett TCR, Hart DNJ 1989 Human dendritic cells stimulate
allogenic T cells in the absence of IL-1. Immunology 67:290–297
30. Bartalena L, Brogioni S, Grasso L, Martino E 1995 Interleukin-6 and the
thyroid. Eur J Endocrinol 132:386–393
31. Rasmussen AK, Feldt-Rasmussen U, Bendtzen K 1993 The effect of inter-
leukin-1 on the thyroid gland. Autoimmunity 16:141–148
32. Zerek-Melen G, Zylinska K, Fryczak J, Mucha S, Stepien H 1994 Influence
of interleukin-1 and antihuman interleukin-1 receptor antibody on the growth
and function of the thyroid gland in rats. Eur J Endocrinol 131:531–534
33. Inokuchi N, Zeki K, Morimoto I, Nakano Y, Fujihira T, Yamashita U, Yanagi-
hara N, Izumi F, Eto S 1995 Stimulatory effect of interleukin-1 alpha on
proliferation through a Ca21/calmodulin-dependent pathway of a human
thyroid carcinoma cell line, NIM 1. Jpn J Cancer Res 86:670–676
34. Nolte A, Bechtner G, Rafferzeder M, Ga¨rtner R 1994 Interleukin-1 beta (IL-1b)
binds to intact porcine thyroid follicles, decreases iodide uptake but has no
effect on cAMP formation or proliferation. Horm Metab Res 26:413–418
35. Nishiyma S, Takada K, Tada H, Takano T, Amino N 1993 Effect of inter-
leukin-6 on cell proliferation of FRTL-5 cells. Biochem Biophys Commun
192:319–323
36. Zeki K, Azuma H, Suzuki H, Morimoto I, Eto S 1991 Effects of interleukin-1
on growth and adenosine 3959-monophasphate generation of the thyroid cell
line FRTL5 cells. Acta Endocrinol 124:60–66
37. Kawakami A, Eguchi K, Matzuoka N, Tsuboi M, Kawabe Y, Ishikawa N, Ito
K, Nagataki S 1996 Thyroid-stimulating hormone inhibits Fas antigen-medi-
ated apoptosis of human thyrocytes in vitro. Endocrinology 137:3163–3169
38. Dubey C, Croft M 1996 Accessory molecule regulation of naive CD4 T cell
activation. Immunol Res 15:114–125
39. Hoermann R, Spitzweg C, Poertl S, Mann K, Heufelder AE, Schumm-Drae-
ger PM 1997 Regulation of intercellular adhesion molecule-1 expression in
human thyroid cells in vitro and human thyroid tissue transplanted to the nude
mouse in vivo: role of Graves’ immunoglobulins and human thyrotropin re-
ceptor. J Clin Endocrinol Metab 82:2048–2055
40. Mooij P (ed) 1993 The thyroid, iodine and autoimmunity. Academic Thesis,
Erasmus University Rotterdam, The Netherlands
41. Li M, Eastman CJ, Boyages SC 1993 Iodine induced lymphocytic thyroiditis
in the BB/W rat: early and late immune phenomena. Autoimmunity
14:181–187
42. Mooij P, Simons PJ, Haan de-Meulman M, Wit de HJ, Drexhage HA 1994 The
effect of thyroid hormones and other iodinated compounds on the transition
of monocytes into veiled/dendritic cells: role of granulocyte-macrophage col-
ony-stimulating factor, tumour necrosis factor-alpha and interleukin-6. J En-
docrinol 140:503–512
43. Xu LL, Warren MK, Rose WL, Gong W, Wang JM 1996 Human recombinant
monocyte chemotactic protein and other C-C chemokines bind and induce
directional migration of dendritic cells in vitro. J Leukocyte Biol 60:365–371
44. Aust G, Hofmann A, Laue S, Ode-Hakim S, Scherbaum WA 1996 Differential
regulation of granulocyte-macrophage colony-stimulating factor mRNA and
protein expression in human thyrocytes and thyroid-derived fibroblasts by
interleukin-1 alpha and tumor necrosis factor-alpha. J Endocrinol 151:277–285
45. Kasai K, Banba N, Motohashi S, Hattori Y, Manaka K, Shimoda SI 1996
Expression of monocyte chemoattractant protein-1 mRNA and protein in
cultured human thyrocytes. FEBS Lett 394:137–140
3156 DENDRITIC CELLS SUPPRESS THYROCYTE GROWTH Endo • 1998
Vol 139 • No 7
 at Medical Library Erasmus MC on December 11, 2006 endo.endojournals.orgDownloaded from 
